The diagram below shows a summary of the KETO-lung trial:
Patients with advanced squamous cell cancer of the lung
Informed consent
Screening
Registration
4x21-day cycle standard-of-care chemo/immunotherapy
[paclitaxel + carboplatin + pembrolizumab] with experimental ketogenic diet therapy [+ 1 week introduction]
Standard-of-care maintenance pembrolizumab: 3-weekly follow-up
Post-maintenance follow-up up to 12-months: attend clinic appointments every 4 weeks for 6 months, then 12 weekly.